Mesenchymal Stem Cells Carrying Viral Fusogenic Protein p14 to Treat Solid Tumors by Inducing Cell–Cell Fusion and Immune Activation
Yao Wang(South China Normal University), Youcai Deng(Central South University), Junnian Zheng(Xuzhou Medical College), Jiuzhou Chen(Huaian First People’s Hospital), Lijun Zheng(Shaoxing University), Jianjie Li(Xuzhou Medical College), Ruirui Li(Capital Medical University), Wen Chen(Changsha Mining and Metallurgy Research Institute (China)), Xunlei Pang(Xuzhou Medical College), Huihuang Zhu(Xuzhou Medical College)
Cited by 3
Related Papers
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function
|Immunity|2015|184
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136